Compare BIO & DOCU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIO | DOCU |
|---|---|---|
| Founded | 1952 | 2003 |
| Country | United States | United States |
| Employees | 7450 | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | EDP Services |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 9.6B |
| IPO Year | N/A | 2018 |
| Metric | BIO | DOCU |
|---|---|---|
| Price | $295.88 | $46.49 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 17 |
| Target Price | ★ $339.75 | $63.33 |
| AVG Volume (30 Days) | 318.0K | ★ 4.5M |
| Earning Date | 04-30-2026 | 06-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.40 |
| Revenue | N/A | ★ $3,219,500,000.00 |
| Revenue This Year | $2.74 | $10.58 |
| Revenue Next Year | $3.20 | $7.33 |
| P/E Ratio | ★ $9.72 | $114.43 |
| Revenue Growth | N/A | ★ 8.16 |
| 52 Week Low | $236.73 | $40.16 |
| 52 Week High | $343.12 | $86.65 |
| Indicator | BIO | DOCU |
|---|---|---|
| Relative Strength Index (RSI) | 53.91 | 52.47 |
| Support Level | $293.88 | $44.43 |
| Resistance Level | $312.51 | $50.24 |
| Average True Range (ATR) | 9.55 | 1.92 |
| MACD | 0.52 | 0.36 |
| Stochastic Oscillator | 72.26 | 95.26 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Docusign offers Agreement Cloud, a broad cloud-based software suite that enables users to automate the agreement process and provide legally binding e-signatures from nearly any device. The company was founded in 2003 and completed its initial public offering in 2018.